Voorbeelden van het gebruik van T-cell in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
CD4 and CD8 T-cell counts begin to rise from weeks 8-12 during treatment
For HIV-1, the receptor is the T-cell surface lymphocyte marker CD4,
Further activation of the adaptive immune response depends on cytokine regulation of T-cell differentiation into subsets of T-cells that serve specific functions to defend against harmful stimuli.
The IC50 values for imatinib mesylate-inhibited T-cell proliferation stimulated by DCs
Following evaluation of T-cell depletion in monkeys, modified protocols were accepted for evaluation in humans.
Her pneumonia's healing, Her t-cell counts are stable Now that they have restarted her therapy.
Mean baseline CD4+ T-cell count was 838 cells/mm3
The PD-1 receptor is a negative regulator of T-cell activity that has been shown to be involved in the control of T-cell immune responses.
mean CD4 T-cell count was about 500 cells/ µL.
and CD4 T-cell depletion is a hallmark of such infections.
Infection with the human T-cell lymphoma/leukemia virus-1(HTLV-1) for example can cause a rare type of T-cell acute lymphocytic leukemia.
Intracellular antibody-mediated degradation is a non-cytotoxic mechanism contrasting with other immune responses such as T-cell killing.
CD8, which are T-cell markers.
The cells implicated in ALL have clonal rearrangements in their immunoglobulin or T-cell receptor genes and express antigen-receptor molecules
Instead, it stimulates the release of interferons, which suppresses the T-cell immune response.
Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as
LUMC researchers think that certain T-cell types are an important link in the process,
alterations in immune function were observed consisting of a 9-fold increase in T-cell dependent antibody response in female pups and thyroid inflammation in one female pup.
Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation,
KEYTRUDA potentiates T-cell responses, including anti-tumour responses,